Are you going to collaborate with competitors by way of a research and development agreement? What measures should be taken to protect your innovations? What are relevant considerations for the manufacture, sale and marketing of drugs?
Sweden is Northern Europe’s largest and most dynamic life science region, which is not only characterized by its considerable focus on qualitative R&D and drug development but also on its close collaboration amongst businesses, universities, and clinical practitioners. The life science sector is a highly regulated area, with high standards of regulatory compliance and governance from the development phase to that of manufacturing and commercialization.
Wistrand assists companies working with pharmaceuticals, biotechnology, medical technology and healthcare regarding all types of issues that are relevant to the life science sector.
We provide advice in areas such as:
- R&D agreements
- License agreements
- Manufacturing agreements
- Distribution and collaboration agreements
- Transaction agreements
- Public procurement
- Capital raisings
- Intellectual property law
- Competition law
- Permits and other regulatory issues
- General Data Protection Regulation (GDPR) and other issues regarding personal data and privacy